Your browser doesn't support javascript.
loading
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Zeuzem, Stefan; Bourgeois, Stefan; Greenbloom, Susan; Buti, Maria; Aghemo, Alessio; Lampertico, Pietro; Janczewska, Ewa; Lim, Seng Gee; Moreno, Christophe; Buggisch, Peter; Tam, Edward; Corbett, Chris; Willems, Wouter; Vijgen, Leen; Fevery, Bart; Ouwerkerk-Mahadevan, Sivi; Ackaert, Oliver; Beumont, Maria; Kalmeijer, Ronald; Sinha, Rekha; Biermer, Michael.
Afiliación
  • Zeuzem S; Department of Medicine, J.W. Goethe University Hospital, Frankfurt am Main, Germany.
  • Bourgeois S; Department of Gastroenterology and Hepatology, ZNA Antwerp, Antwerp, Belgium.
  • Greenbloom S; Toronto Digestive Disease Associates, Inc., Vaughan, ON, Canada.
  • Buti M; Hospital Vall d'Hebron and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
  • Aghemo A; Humanitas University and Research Hospital, Rozzano, Italy.
  • Lampertico P; CRC "AM e A Migliavacca," Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università di Milano, Milan, Italy.
  • Janczewska E; Outpatients Clinic for Hepatology, ID Clinic, Myslowice, Poland.
  • Lim SG; Medical University of Silesia, School of Public Health in Bytom, Department of Basic Medical Sciences, Bytom, Poland.
  • Moreno C; Division of Gastroenterology and Hepatology, Department of Medicine, Yong Loo Lin School of Medicine, National University Health System, Singapore.
  • Buggisch P; CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Tam E; Institute for Interdisciplinary Medicine, Hamburg, Germany.
  • Corbett C; LAIR Centre, Vancouver, BC, Canada.
  • Willems W; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Vijgen L; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Fevery B; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Ouwerkerk-Mahadevan S; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Ackaert O; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Beumont M; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Kalmeijer R; Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Sinha R; Janssen Research & Development, LLC, Titusville, NJ.
  • Biermer M; Janssen Research & Development, LLC, Titusville, NJ.
Hepatology ; 69(6): 2349-2363, 2019 06.
Article en En | MEDLINE | ID: mdl-30693573
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uridina / Bencimidazoles / Carbamatos / Hepacivirus / Hepatitis C Crónica / Alanina / Simeprevir / Medición de Resultados Informados por el Paciente / Indoles Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uridina / Bencimidazoles / Carbamatos / Hepacivirus / Hepatitis C Crónica / Alanina / Simeprevir / Medición de Resultados Informados por el Paciente / Indoles Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: Alemania